Semorinemab (RG6100) is a humanised monoclonal antibody targeting the N-terminal domain of tau protein with a Kd of 3.8 nM, suitable for Alzheimers disease research. It binds all six human tau isoforms and reduces tau accumulation.
Purity:
0.972
CAS Number:
[2159141-27-0]
Target:
Microtubule Associated
* VAT and and shipping costs not included. Errors and price changes excepted
